SORT BY

FILTER BY

also on other fortune lists

company facts

f500 stats

Fortune 500

Courtesy of Quintiles IMS Holdings

390

Quintiles IMS Holdings

Q

The global contract-research firm conducts clinical trials and other activities for pharmaceutical companies.

Looking for leads, investment insights, or competitive intelligence?

CEO

Ari Bousbib

CEO Title

Chairman, President & Chief Executive Officer

Sector

Health Care

Industry

Health Care: Pharmacy and Other Services

HQ Location

Durham, NC

Years on Fortune 500 List

4

Employees

50,000

Acquired IMS Health Holdings (2015 rank: 746), Oct. 3, 2016.Profile provided by S&P Global.
Quintiles IMS Holdings is also featured in these fortune lists
Key Financials (Last Fiscal Year)
$ millions% change
Revenues ($M)$6,87819.9%
Profits ($M)$115.0-70.3%
Assets ($M)$21,208
Total Stockholder Equity ($M)$8,633
Market Value — as of March 31, 2017 ($M)$18,999
Profit Ratios
Profit as % of Revenues1.7%
Profits as % of Assets0.5%
Profits as % of Stockholder Equity1.3%
Earnings Per Share (Last Fiscal Year)
Earnings Per Share ($)0.76
EPS % Change (from 2015)-75.3%
EPS % Change (5 year annual rate)-
EPS % Change (10 year annual rate)-
Total Return
Total Return to Investors (2016)10.8%
Total Return to Investors (5 year, annualized)-
Total Return to Investors (10 year, annualized)-
STOCK QUOTE
()0.00 0.00 (0)
  • Previous Close:
  • Market Cap: NaNB
  • Next Earnings Date:
  • High:
  • Low:
  • 52 Week High:
  • 52 Week Low:
  • 52 Week Change %: 0.00
  • P/E Ratio: n/a
  • EPS:
  • Dividend Yield: n/a

News about Quintiles IMS Holdings

These Are Hedge Funds' Best Stock Picks From the Sohn Conference

Wall Street stock-pickers from David Einhorn to Bill Ackman offered their top ideas.

Read More →
Carly Fiorina's troubling telecom past

Before she became the controversial CEO of HP, Senate candidate Carly Fiorina was a star at Lucent. What does her time at the telecom disaster say about her?

Read More →